Home / Inspections / 606526

FDA Inspection 606526 — Pfizer Inc.

Pfizer Inc. — FEI 2416101

The FDA completed an inspection of Pfizer Inc. on August 10, 2009 in New York, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 10, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1176364 (NAI Fri Jul 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 946884 (VAI Wed Aug 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805292 (VAI Mon Oct 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 785976 (NAI Wed Jun 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources